Aquilo Capital Management, LLC

Insider Reports History

Entity
Company
Location
One Letterman Drive, Suite D4900, Building D, San Francisco, CA
Signature
Aquilo Capital Management, LLC By: Marc Schneidman, its Managing Member, /s/ Marc Schneidman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aquilo Capital Management, LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Spero Therapeutics, Inc. 10%+ Owner Common Stock, $0.001 par value 3.42M $4.34M $1.27 Sep 22, 2022 Indirect

Insider Reports Filed by Aquilo Capital Management, LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRO Spero Therapeutics, Inc. Sep 22, 2022 2 -$4.28M 4 Sep 26, 2022 10%+ Owner
SPRO Spero Therapeutics, Inc. Apr 26, 2022 1 $208K 4 Apr 28, 2022 10%+ Owner
SPRO Spero Therapeutics, Inc. Mar 30, 2022 2 $439K 4 Mar 31, 2022 10%+ Owner
SPRO Spero Therapeutics, Inc. Mar 14, 2022 2 $181K 4 Mar 16, 2022 10%+ Owner
SPRO Spero Therapeutics, Inc. Feb 28, 2022 2 $427K 4 Mar 2, 2022 10%+ Owner
SPRO Spero Therapeutics, Inc. Feb 18, 2022 1 $137K 4 Feb 23, 2022 10%+ Owner
SPRO Spero Therapeutics, Inc. Jan 31, 2022 1 $1.45M 4 Feb 1, 2022 10%+ Owner
SPRO Spero Therapeutics, Inc. Jan 24, 2022 1 $17.4K 4 Jan 26, 2022 10%+ Owner
SPRO Spero Therapeutics, Inc. Jan 18, 2022 1 $602K 4 Jan 20, 2022 10%+ Owner
SPRO Spero Therapeutics, Inc. Jan 10, 2022 1 $115K 4 Jan 12, 2022 10%+ Owner
SPRO Spero Therapeutics, Inc. Dec 29, 2021 3 $3.86M 4 Jan 3, 2022 10%+ Owner
SPRO Spero Therapeutics, Inc. Oct 29, 2021 1 $2.63M 4 Nov 2, 2021 10%+ Owner
SPRO Spero Therapeutics, Inc. Sep 30, 2021 1 $2.51M 4 Oct 4, 2021 10%+ Owner
SPRO Spero Therapeutics, Inc. Sep 13, 2021 2 $861K 4 Sep 15, 2021 10%+ Owner
SPRO Spero Therapeutics, Inc. Sep 9, 2021 1 $458K 4 Sep 10, 2021 10%+ Owner
SPRO Spero Therapeutics, Inc. Aug 30, 2021 2 $1.71M 4 Sep 1, 2021 10%+ Owner
SPRO Spero Therapeutics, Inc. Aug 26, 2021 2 $616K 4 Aug 27, 2021 10%+ Owner
SPRO Spero Therapeutics, Inc. Aug 20, 2021 3 $6.19M 4 Aug 24, 2021 10%+ Owner